Conference · Budapest, Hungary
Bioavailability / Bioequivalence, Dissolution and Biowaivers
Health · Pharmaceuticals · Medical Equipment
Key numbers
- Editions on record
- 1first in 2014
About Bioavailability / Bioequivalence, Dissolution and Biowaivers
Save the date for 2014's leading conference for clinical, R&D and regulatory teams working with bioequivalence studies, biowaivers and dissolution testing. Join over 22 regulatory authority and industry experts as they share their experience across key developments and challenges facing the industry.
Speakers Include
Helmut Schütz Director BEBAC, Austria
Jean-Michel Cardot Department of Biopharmaceutics and Pharmaceutical Technology University d’Auvergne
Carrie Coutant Principal Research Scientist Eli Lilly and Company
Marika Pečená Senior Clinical Development Manager Zentiva k.s., a Sanofi company
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 14–15 May 2014 | Zara Continental Hotel Budapest, Hungary | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Bioavailability / Bioequivalence, Dissolution and Biowaivers?
The next dates haven't been confirmed. The last edition we have on record was 14–15 May 2014.
Where is it held?
The last edition we have was at Zara Continental Hotel, Budapest, Hungary.